Virax Biolabs Group Limited (VRAX) vs XORTX Therapeutics Inc. (XRTX)
A side-by-side comparison of Virax Biolabs Group Limited and XORTX Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
VRAX
Virax Biolabs Group Limited
$2.03HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
XRTX
XORTX Therapeutics Inc.
$1.73HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — VRAX vs XRTX
growth of $100 · dividends reinvested · last 4yVRAX -99.9% (-84.8%/yr)XRTX -97.4% (-59.8%/yr)XRTX compounded faster over this window
Log scale — wide-divergence pair
VRAX XRTX
VRAX vs XRTX: by the numbers
- •XRTX is the larger company ($481786 vs $378849 market cap).
- •Both run net losses; XRTX's is the smaller (0.00% vs -40439.10% net margin).
Metrics side by side
Valuation
| Metric | VRAX | XRTX |
|---|---|---|
| P/B ratio | 0.05 | 0.09 |
Profitability
| Metric | VRAX | XRTX |
|---|---|---|
| Gross margin | 61.90% | 0.00% |
| Operating margin | -51515.17% | 0.00% |
| Net margin | -40439.10% | 0.00% |
| ROE | -66.30% | -68.17% |
| ROIC | -83.46% | -71.43% |
Growth (annualized)
| Metric | VRAX | XRTX |
|---|---|---|
| Revenue CAGR (5Y) | -36.87% | N/A |
| Total return CAGR (5Y) | N/A | -63.52% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.